191 related articles for article (PubMed ID: 32898182)
1. Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection.
Singh KP; Zerbato JM; Zhao W; Braat S; Deleage C; Tennakoon GS; Mason H; Dantanarayana A; Rhodes A; Rhodes JW; Torresi J; Harman AN; Revill PA; Crane M; Estes JD; Avihingsanon A; Lewin SR; Audsley J
PLoS Pathog; 2020 Sep; 16(9):e1008744. PubMed ID: 32898182
[TBL] [Abstract][Full Text] [Related]
2. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G;
Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
[TBL] [Abstract][Full Text] [Related]
4. HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.
Maponga TG; Andersson MI; van Rensburg CJ; Arends JE; Taljaard J; Preiser W; Glashoff RH
BMC Infect Dis; 2018 May; 18(1):214. PubMed ID: 29739341
[TBL] [Abstract][Full Text] [Related]
5. Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals.
Wang XQ; Zerbato JM; Avihingsanon A; Fisher K; Schlub T; Rhodes A; Audsley J; Singh KP; Zhao W; Lewin SR; Palmer S
J Virol; 2022 Aug; 96(16):e0058822. PubMed ID: 35916523
[TBL] [Abstract][Full Text] [Related]
6. Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia.
Vinikoor MJ; Hamusonde K; Muula G; Asombang M; Riebensahm C; Chitundu H; Sunkuntu-Sichizya V; Bhattacharya D; Sinkala E; Lauer G; Chung R; Mbewe W; Egger M; Bosomprah S; Wandeler G
Clin Infect Dis; 2024 Jun; 78(6):1583-1590. PubMed ID: 37997691
[TBL] [Abstract][Full Text] [Related]
7. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia.
Vinikoor MJ; Mulenga L; Siyunda A; Musukuma K; Chilengi R; Moore CB; Chi BH; Davies MA; Egger M; Wandeler G;
Trop Med Int Health; 2016 Nov; 21(11):1435-1441. PubMed ID: 27499385
[TBL] [Abstract][Full Text] [Related]
8. Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals.
Lee Z; Nishikawa S; Gao S; Eksteen JB; Czub M; Gill MJ; Osiowy C; van der Meer F; van Marle G; Coffin CS
PLoS One; 2015; 10(9):e0137568. PubMed ID: 26390290
[TBL] [Abstract][Full Text] [Related]
9. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A;
Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy.
Weissmann L; Picone CM; Gouvêa MSG; Ferreira PRA; Viana MSVB; Pinho JRR; Cassenote AJF; Segurado AC
Braz J Infect Dis; 2019; 23(6):441-450. PubMed ID: 31715124
[TBL] [Abstract][Full Text] [Related]
11. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
[TBL] [Abstract][Full Text] [Related]
13. HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.
Zerbato JM; Avihingsanon A; Singh KP; Zhao W; Deleage C; Rosen E; Cottrell ML; Rhodes A; Dantanarayana A; Tumpach C; Tennakoon S; Crane M; Price DJ; Braat S; Mason H; Roche M; Kashuba ADM; Revill PA; Audsley J; Lewin SR
EBioMedicine; 2023 Jan; 87():104391. PubMed ID: 36502576
[TBL] [Abstract][Full Text] [Related]
14. Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana.
Stockdale AJ; Phillips RO; Beloukas A; Appiah LT; Chadwick D; Bhagani S; Bonnett L; Sarfo FS; Dusheiko G; Geretti AM;
Clin Infect Dis; 2015 Sep; 61(6):883-91. PubMed ID: 26021992
[TBL] [Abstract][Full Text] [Related]
15. Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen.
Aurpibul L; Kanjanavanit S; Leerapun A; Puthanakit T
J Int Assoc Provid AIDS Care; 2019; 18():2325958218823259. PubMed ID: 30798669
[TBL] [Abstract][Full Text] [Related]
16. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.
Boyd A; Bottero J; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Serfaty L; Lacombe K
J Int AIDS Soc; 2017 Feb; 20(1):21426. PubMed ID: 28362068
[TBL] [Abstract][Full Text] [Related]
17. Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults.
Hawkins C; Christian B; Fabian E; Macha I; Gawile C; Mpangala S; Ulenga N; Thio CL; Ammerman LR; Mugusi F; Fawzi W; Green R; Murphy R
J Acquir Immune Defic Syndr; 2017 Nov; 76(3):298-302. PubMed ID: 29016448
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfection.
Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Zoulim F; Lacombe K; Boyd A
AIDS; 2020 Nov; 34(13):1943-1949. PubMed ID: 32773480
[TBL] [Abstract][Full Text] [Related]
19. Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy.
Singh KP; Avihingsanon A; Zerbato JM; Zhao W; Braat S; Tennakoon S; Rhodes A; Matthews GV; Fairley CK; Sasadeusz J; Crane M; Audsley J; Lewin SR
EBioMedicine; 2024 Apr; 102():105054. PubMed ID: 38518655
[TBL] [Abstract][Full Text] [Related]
20. Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up.
Calin R; Guiguet M; Desire N; Imbert-Bismut F; Munteanu M; Poynard T; Valantin MA; Stitou H; Katlama C; Thibault V
J Clin Virol; 2013 Oct; 58(2):408-14. PubMed ID: 23958588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
